Information Technology · Printed Circuit Boards

KE Kimball Electronics, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 160675786 filings
Russell 2000

KE at a glance

Kimball Electronics, Inc. (KE, SEC CIK 1606757) filed its latest 10-K annual report on August 19, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 17, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended June 30, 2026 (FY2026), Kimball Electronics, Inc. (KE) reported revenue of $1.4 billion (down 3.7% from FY2025) and net income of $28.0 million. Diluted EPS was $1.13.
  • As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding Kimball Electronics, Inc. (KE) shares worth $288.0 million in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$1.4B
−3.7% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
29 funds
$288.0M · +0 vs prior quarter
Latest 8-K
Nov 17, 2026
Item 5.02 · Item 5.07 · Item 8.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Jun 30, 2026

Full analysis →

Management Discussion & Analysis

  • Revenue $1,431.4M, down 4% YoY from $1,486.7M; automotive sales fell 7% to $656.9M, medical grew to $412.8M (+4%), industrial down 5% to $361.7M
  • Operating margin 4.6% vs 3.1%; gross margin 8.2% vs 7.0%; S&A 4.3% vs 3.4%; net income $28M, EPS $1.13 vs $17M, $0.68, +64.6%
  • Medical segment best performer with 4% sales growth and margin contribution; automotive worst with 7% sales decline due to lost major program
  • Operating cash flow $72.3M vs $183.9M; capex $51.7M vs $33.7M (incl. Indianapolis medical facility); repurchased $11.9M stock, total buybacks $115.6M to date; debt reduced $30.9M
  • 2027 outlook includes Helvoet acquisition integration, new Indianapolis facility start-up costs, tariff uncertainties, ongoing automotive weakness offset by medical growth, and tax rate variability due to geographic earnings mix

Risk Factors

  • Regulatory/legal risk: Supreme Court vacated IEEPA tariffs imposed in Feb 2025; resulting tariff refunds began in Q4 FY2026 impacting customer cost recoveries
  • Geopolitical/macroeconomic threat: Ongoing Middle East conflict involving U.S., Israel, and Iran risks supply chain disruptions and freight/component cost increases
  • Operational/supply chain vulnerability: Closure of Tampa facility completed FY2025; production shifted mainly to Mexico and Jasper plants, with ongoing restructuring expected
  • Competitive/market disruption risk: Loss of major automotive program in FY2026 caused 7% sales decline; pressure from competitors in mid-sized EMS space noted
  • Financial/structural risk: Acquisition of Helvoet (approx. $103M paid Jul 2026) creating integration costs and synergies risk; liquidity strong with $403.8M cash + credit lines as of June 30, 2026

Business Overview

  • Contract manufacturer and CDMO serving global customers with integrated supply chain solutions, extensive international operations in China, Mexico, Europe, India, Thailand
  • Completed largest acquisition to date: Helvoet on July 1, 2026, expanding manufacturing footprint into India and the Netherlands and adding precision molded plastics and medical device capabilities
  • Increased focus on AI deployment across engineering, manufacturing, quality, and back-office functions; compliance with evolving AI-specific laws (EU AI Act, Colorado AI Act) emphasized
  • Inflation, tariffs, and supply chain disruptions increased costs; tariffs recovered mainly through contractual pass-through; currency fluctuations positively impacted net sales by 2%
  • Workforce and facility expansion complexity heightened, alongside intensified cybersecurity risks and regulatory compliance pressures, including global data privacy and sustainability requirements

AI summary of the KE 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material risk-factor changes identified versus the June 30, 2026 Form 10-K

Management Discussion & Analysis

  • Revenue $390.8M, up 7% YoY from $365.6M, with medical sales $115.7M vs $101.6M
  • Gross margin 7.9% vs 7.9% YoY, operating margin 3.2% vs 4.0%, net income $2.6M vs $10.1M
  • Best vertical: medical, $115.7M vs $101.6M; worst growth detail: automotive $170.5M vs $164.4M
  • Operating cash flow $(19.3)M vs $8.1M; Helvoet acquisition investment $101.0M, financed by $119.2M net borrowings
  • Fiscal 2027 headwinds: automotive demand pressure, tariff uncertainty, Helvoet integration costs, Indianapolis facility start-up costs

AI summary of the KE 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 17, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • New independent director Rebecca S. Sidelinger appointed effective November 13, 2026, strengthening operating expertise
  • Former Flex executive and Honeywell Aerospace leader brings experience across automotive, healthcare, industrial, and engineered products

Item 5.07: Submission of Matters to a Vote of Security Holders

  • All three Class III directors reelected for three-year terms, with 97% to 99% of votes cast in favor
  • Deloitte & Touche ratified as fiscal 2027 auditor, receiving 98% approval

Item 8.01: Other Events

  • Robert J. Phillippy continuing as Board Chair, preserving leadership continuity
  • Committees and chair assignments unchanged from the prior year
Filed Nov 4, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q1 fiscal 2026 earnings release issued for quarter ended September 30, 2026
  • Exhibit 99.1 contains the company’s quarterly financial results and management commentary

Item EX-99.1: Item EX-99.1

  • Q1 FY2027 sales $390.8M, up 7% year over year, with 3% organic growth signaling resumed top-line momentum
  • Medical sales rose 14%, including 9% organic growth, reinforcing portfolio diversification and supporting Helvoet acquisition rationale
Filed Aug 12, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q4 sales $371.6M, down 2% YoY, while adjusted operating margin declined to 4.9% from 5.2%
  • FY2026 sales $1,431.4M, down 4%; Medical grew 4% to $412.8M and reached 29% of sales

Item 2.02: Results of Operations and Financial Condition

  • Earnings release covers fourth quarter ended June 30, 2026
  • Exhibit 99.1 contains Kimball Electronics’ fiscal 2026 fourth-quarter results

AI summaries of KE 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for KE

Don't miss the next KE filing

  • Alerts as it files. A push when KE files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut KE, by share count.
  • Ask anything. An AI agent that reads every KE filing and answers with sources.

KE alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Sidelinger RebeccaANov 17, 2026$19.74
Holcomb MicheleANov 13, 2026$19.74
Phillips Richard DGNov 13, 2026-
Repplier Colleen CANov 13, 2026$19.74
Vadaketh Tom GeorgeANov 13, 2026$19.74
Van Deursen HollyANov 13, 2026$19.74
Lampert Gregory J.ANov 13, 2026$19.74
THAXTON GREGORY AANov 13, 2026$19.74

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$1.5B$1.4B
Gross Profit-$104.4M$117.5M
Operating Income-$45.5M$66.1M
Net Income-$17.0M$28.0M
Gross Margin-7.0%8.2%
Op. Margin-3.1%4.6%
Net Margin-1.1%2.0%
Balance Sheet
Total Assets$1.2B$1.1B$1.1B
Equity$540.5M$569.9M$585.1M
ROE-3.0%4.8%
Per Share
EPS-$0.68$1.13
Cash Flow
Operating CF-$183.9M$72.3M
CapEx-$33.3M$51.5M

Source: XBRL data in Kimball Electronics, Inc. (KE)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate KE share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
KE shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202629$288.0M
Q2 202629$269.4M
Q1 202628$240.2M
Q4 202529$272.0M
Q3 202528$297.9M
Q2 202527$187.9M
Q1 202523$125.2M
Q4 202419$113.4M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 212 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

KE filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 19, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
8-KNov 17, 2026Analysis-
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
10-QNov 5, 2026Analysis
8-KNov 4, 2026Analysis-
4Sep 4, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
10-KAug 19, 2026Analysis
SC 13GAug 14, 2026-
8-KAug 12, 2026Analysis-
8-KJul 1, 2026Analysis-

Related Information Technology companies

All Information Technology →

KE SEC filings: frequently asked questions

Which institutions hold KE stock?

As of September 30, 2026, the largest Kimball Electronics, Inc. (KE) holders among the 13F filers tracked by SignalX were BlackRock ($70.1 million), Dimensional Fund Advisors ($45.2 million), Bank of America Corp ($34.3 million), Vanguard Capital Management LLC ($27.8 million), Vanguard Portfolio Management LLC ($21.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was KE's revenue in fiscal year 2026?

For the fiscal year ended June 30, 2026 (FY2026), Kimball Electronics, Inc. (KE) reported revenue of $1.4 billion (down 3.7% from FY2025) and net income of $28.0 million. Diluted EPS was $1.13. The figures come from the XBRL data in the 10-K.

What are the main risks in KE's latest 10-K?

In the 10-K filed August 19, 2026, Kimball Electronics, Inc. (KE) flagged: Regulatory/legal risk: Supreme Court vacated IEEPA tariffs imposed in Feb 2025; resulting tariff refunds began in Q4 FY2026 impacting customer cost recoveries. Geopolitical/macroeconomic threat: Ongoing Middle East conflict involving U.S., Israel, and Iran risks supply chain disruptions and freight/component cost increases. (AI summary of the Risk Factors section.)

What did KE report in its latest 8-K?

Kimball Electronics, Inc. (KE) filed an 8-K on November 17, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 8.01 (Other Events). New independent director Rebecca S. Sidelinger appointed effective November 13, 2026, strengthening operating expertise.

What are the latest KE SEC filings?

Kimball Electronics, Inc. (KE) filed its latest 10-K annual report on August 19, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 17, 2026 and a Form 4 insider filing on November 19, 2026.

What is KE's SEC CIK number?

Kimball Electronics, Inc. (KE)'s SEC Central Index Key (CIK) is 1606757. EDGAR lists every KE filing under that number.

Ask anything about KE

The research agent reads KE's filings, financials, insider trades and 13F holders, then answers with sources.